These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1378770)

  • 1. HPA-related CSF neuropeptides in suicide attempters.
    Träskman-Bendz L; Ekman R; Regnéll G; Ohman R
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):99-106. PubMed ID: 1378770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between plasma-neuropeptides and temperament dimensions differ between suicidal patients and healthy controls.
    Westrin A; Engstöm G; Ekman R; Träskman-Bendz L
    J Affect Disord; 1998 Apr; 49(1):45-54. PubMed ID: 9574859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results.
    Brunner J; Keck ME; Landgraf R; Uhr M; Namendorf C; Bronisch T
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):489-94. PubMed ID: 12208567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
    Jokinen J; Mårtensson B; Nordström AL; Nordström P
    J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters.
    Brunner J; Stalla GK; Stalla J; Uhr M; Grabner A; Wetter TC; Bronisch T
    J Psychiatr Res; 2001; 35(1):1-9. PubMed ID: 11287050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder.
    Westrin A; Ekman R; Träskman-Bendz L
    Biol Psychiatry; 1998 May; 43(10):734-9. PubMed ID: 9606527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt.
    Westrin A; Ekman R; Träskman-Bendz L
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):205-11. PubMed ID: 10208289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters.
    Chatzittofis A; Nordström P; Hellström C; Arver S; Åsberg M; Jokinen J
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1280-7. PubMed ID: 23453639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of weariness of life, suicide ideations and suicide attempt on HPA axis regulation in depression.
    Hennings JM; Ising M; Uhr M; Holsboer F; Lucae S
    Psychoneuroendocrinology; 2021 Sep; 131():105286. PubMed ID: 34090135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans.
    Elias E; Benrick A; Behre CJ; Ekman R; Zetterberg H; Stenlöf K; Wallenius V
    J Neuroendocrinol; 2011 Jun; 23(6):501-7. PubMed ID: 21438929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
    Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
    Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin, Anxiety Symptoms, and Hypothalamic-Pituitary-Adrenal Axis Activity among Drug-Free, Female Suicide Attempters.
    Ambrus L; Westling S
    Neuropsychobiology; 2019; 78(3):145-152. PubMed ID: 31189176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary cortisol and suicidal behavior--a follow-up study.
    Lindqvist D; Isaksson A; Träskman-Bendz L; Brundin L
    Psychoneuroendocrinology; 2008 Sep; 33(8):1061-8. PubMed ID: 18672335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters.
    Westrin A; Niméus A
    Eur Psychiatry; 2003 Jun; 18(4):166-71. PubMed ID: 12814849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amine metabolites, neuroendocrine findings, and personality dimensions as correlates of suicidal behavior.
    Banki CM; Arató M
    Psychiatry Res; 1983 Dec; 10(4):253-61. PubMed ID: 6199807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L
    ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters.
    Ambrus L; Lindqvist D; Träskman-Bendz L; Westrin Å
    Nord J Psychiatry; 2016 Nov; 70(8):575-81. PubMed ID: 27216156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
    J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    Jokinen J; Nordström AL; Nordström P
    Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amine metabolites and neuroendocrine responses related to depression and suicide.
    Banki CM; Arató M
    J Affect Disord; 1983 Aug; 5(3):223-32. PubMed ID: 6193156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.